When would I use medical therapies for the treatment of primary hyperparathyroidism? - Wikidata - wikimedia - TriplyDB

When would I use medical therapies for the treatment of primary hyperparathyroidism?

When would I use medical therapies for the treatment of primary hyperparathyroidism?

http://www.wikidata.org/entity/Q43662645

about

Primary hyperparathyroidism Elevated PTH with normal serum calcium level: a structured approach.

P2860

Q26764920-22F08988-4F63-4CA7-934B-F4202EE4B884 Q38759343-0056F527-B7C0-4293-AD3C-128C40BE39F7

P2860

When would I use medical therapies for the treatment of primary hyperparathyroidism?

http://www.wikidata.org/entity/Q43662645

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@en

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@nl

type

label

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@en

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@nl

prefLabel

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@en

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@nl

P1433

Q43662645-99459EBA-1EC8-4650-8AE7-542736B61DB7

P1476

Q43662645-AB4646B8-D17D-49EA-9681-D037E0159A37

P2093

Q43662645-6B54069D-708C-45FF-8569-375DB136F9FD

P2860

Q43662645-0346103E-8EB1-4CE6-8D93-791CD2A2A662

Q43662645-0D57F27F-B0B7-493D-A42F-AD8B583576FF

Q43662645-22EC7875-571E-4F01-91B0-D26DEC0BACE8

Q43662645-2E029571-13C1-4F2F-80A9-C401DA0AA803

Q43662645-36AB60AF-BA10-4FC5-B207-1D52D097C0DA

Q43662645-383F1A96-87AB-4DC5-BECA-4826EA4E839C

Q43662645-3ADE91F6-02AD-4766-AE3E-00438B1C2863

Q43662645-51F8520D-5022-4D93-B283-080DFADAF034

Q43662645-5D06C002-2E57-414F-8BB1-D818B761A6B1

Q43662645-642DF6DA-7831-43A7-906C-347C83E3C2D8

P304

Q43662645-456A0FDB-11B9-4D61-B813-8679DEB0C77B

P31

Q43662645-71E31694-FBE7-43F2-BF4E-A10448A38060

P356

Q43662645-A7FA6F9B-DA8C-49DA-9DB7-BCFD2274B39C

P433

Q43662645-E1986268-5DDF-4690-BF58-7B30DDE32388

P478

Q43662645-CF5C0EBD-1008-4F62-BED8-190433D61968

P50

Q43662645-5FA94D9F-B4A6-49EA-9095-0C404F55FE88

P577

Q43662645-B50B316B-1AA8-45BE-AAE5-433D33296FAC

P5875

Q43662645-92D8AE20-B165-4961-9616-DBA757CBD611

P698

Q43662645-8B5C3BC9-C3A7-40BB-825C-229B61B5B660

P921

Q43662645-E7D9875B-1577-482E-8A98-D44A8D69129D

P356

P1433

Clinical Endocrinology

P1476

When would I use medical therapies for the treatment of primary hyperparathyroidism?

@en

P2093

Neil J Gittoes

http://www.w3.org/2001/XMLSchema#string

P2860

Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.

Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop

Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism

Clinical practice. Hypercalcemia associated with cancer.

Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism.

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

P304

770-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.12344

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Rachel K Crowley

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264303116

http://www.w3.org/2001/XMLSchema#string

P698

24111629

http://www.w3.org/2001/XMLSchema#string

P921

hyperparathyroidism